Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.45 |
| ▸ | MAOA | P21397 | 3/20 | 0.40 |
| ▸ | PRKCI | P41743 | 1/20 | 0.40 |
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7389121 | 0.82 | MAPT (0.49) | MAOBCASP1CASP7HSD17B10HRH3 | |
| SCHEMBL30821349 | 0.82 | MAPT (0.49) | MAOBCASP1CASP7HSD17B10HRH3 | |
| SCHEMBL2921166 | 0.77 | GRM5 (0.64) | MAOBHSD17B10MAOAGRM5 | |
| SCHEMBL4815217 | 0.77 | MAOB (0.49) | MAOBCASP1CASP7HSD17B10HRH3 | |
| SCHEMBL15547058 | 0.76 | BRD4 (0.50) | MAOBCASP1CASP7HSD17B10HRH3 | |
| SCHEMBL27925402 | 0.75 | MAOB (0.45) | MAOBCASP1CASP7HSD17B10HRH3 | |
| SCHEMBL7389120 | 0.74 | HSD17B10 (0.62) | MAOBCASP1CASP7HSD17B10HRH3 | |
| SCHEMBL31711410 | 0.74 | HSD17B10 (0.62) | MAOBCASP1CASP7HSD17B10HRH3 | |
| SCHEMBL268592 | 0.74 | KDM4E (0.56) | MAOBCASP1CASP7HSD17B10HRH3 | |
| SCHEMBL17604746 | 0.73 | MAOB (0.52) | MAOBCASP1CASP7HSD17B10HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4392410-A1 | TRANSCRIPTION FACTOR BRN2 INHIBITORY COMPOUNDS FOR USE AS THERAPEUTICS | The University of British Columbia (CA) | 2024-07-03 | — | — | EP | disclosed |
| WO-2023023853-A1 | TRANSCRIPTION FACTOR BRN2 INHIBITORY COMPOUNDS FOR USE AS THERAPEUTICS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-03-02 | — | — | WO | disclosed |